NCT00602602 2020-04-27
Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
Clinical Trials
11 trialsNCT03820921 2019-01-29
SUCCESS
Ponderas Academic Hospital
Unknown
NCT01234935 2018-01-09
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
Translational Oncology Research International
Phase 2 Completed
NCT00900016 2017-09-11
Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery
Fox Chase Cancer Center
Completed
NCT00470535 2017-02-23
Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Roswell Park Cancer Institute
Phase 2 Terminated
NCT01413022 2016-09-19
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Washington University School of Medicine
Phase 1 Completed
NCT01488552 2016-08-18
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
Pancreatic Cancer Research Team
Phase 1/2 Completed
NCT00544193 2015-06-08
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
City of Hope Medical Center
Phase 1 Completed
NCT00482625 2014-10-16
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00369109 2013-04-08
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
Barbara Ann Karmanos Cancer Institute
Completed
NCT00900094 2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed